UK authorizes Pfizer/BioNTech vaccine, rollout to begin next week. It’s the first country in the world to approve the Pfizer/BioNTech vaccine.
A pandemic of the novel coronavirus has now infected more than 63.7 million people and killed over 1.4 million worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.
Operation Warp Speed’s chief science adviser hopes Pfizer/BioNTech vaccine is approved next week. Dr. Moncef Slaoui, chief science adviser to Operation Warp Speed, said he expects the U.S. Food and Drug Administration “to reach a similar conclusion” to the United Kingdom’s approval of a COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech. “I hope by the 10th or 11th of December the Pfizer vaccine is approved,” Slaoui told.
Slaoui urged Americans to “listen to the experts” and trust the vaccine approval process. He described a vaccine as “an insurance against this virus.” “This is what will get us out of the pandemic,” he said. UK authorizes Pfizer/BioNTech vaccine, rollout to begin next week
The U.K. Department of Health and Social Care announced Wednesday that it has accepted the recommendation from the country’s drug regulator to grant a temporary authorization for emergency use of the Pfizer/BioNTech vaccine, called BNT162b2. The Medicines and Healthcare products Regulatory Agency (MHRA) concluded that the vaccine met its standards of safety, quality and effectiveness.
The United Kingdom is the first country in the world to approve the Pfizer/BioNTech vaccine. The companies said in a joint press release Wednesday that they are anticipating further regulatory decisions across the globe in the coming days and weeks and are ready to deliver vaccine doses pending authorizations or approvals.
“Today’s Emergency Use Authorization in the U.K. marks a historic moment in the fight against COVID-19,” Pfizer chairman and CEO Albert Bourla said in a statement. “As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world. With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.”
Pfizer and BioNTech had already agreed to supply the United Kingdom with 40 million doses of BNT162b2 once authorized for emergency use. Now that the vaccine is authorized, the companies will immediately begin delivering doses, the first of which is expected to arrive on U.K. soil in the coming days. The rest of the doses will arrive in stages, with complete delivery fulfillment expected in 2021, according to the press release.
Wednesday, Dec 2, 2020
Content source:
Please Check out file at the following link
High hopes for COVID-19 vaccine in Iran
Moderna’s Vaccine Candidate Against COVID-19
